Trial Outcomes & Findings for Influence of Fibrin Glue on Seroma Formation After Modified Radical Mastectomy (NCT NCT00909649)

NCT ID: NCT00909649

Last Updated: 2009-05-28

Results Overview

the mean total drainage volume

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

50 participants

Primary outcome timeframe

within 30 days postoperative

Results posted on

2009-05-28

Participant Flow

medical clinic

Participant milestones

Participant milestones
Measure
Fibrin Group
Non Fibrin Group
Overall Study
STARTED
25
25
Overall Study
COMPLETED
25
25
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Influence of Fibrin Glue on Seroma Formation After Modified Radical Mastectomy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Fibrin Group
n=25 Participants
Non Fibrin Group
n=25 Participants
Total
n=50 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0.0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
22 Participants
n=5 Participants
22 Participants
n=7 Participants
44.0 Participants
n=5 Participants
Age, Categorical
>=65 years
3 Participants
n=5 Participants
3 Participants
n=7 Participants
6.0 Participants
n=5 Participants
Age Continuous
52.2 years
STANDARD_DEVIATION 11.5 • n=5 Participants
51.6 years
STANDARD_DEVIATION 10.8 • n=7 Participants
51.9 years
STANDARD_DEVIATION 10.7 • n=5 Participants
Sex: Female, Male
Female
25 Participants
n=5 Participants
25 Participants
n=7 Participants
50.0 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0.0 Participants
n=5 Participants
Region of Enrollment
Egypt
25 participants
n=5 Participants
25 participants
n=7 Participants
50.0 participants
n=5 Participants

PRIMARY outcome

Timeframe: within 30 days postoperative

Population: ITT

the mean total drainage volume

Outcome measures

Outcome measures
Measure
Fibrin Group
n=25 Participants
Non Fibrin Group
n=25 Participants
Seroma Formation
770.48 ml
Standard Deviation 70.81
1089.51 ml
Standard Deviation 75.8

Adverse Events

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Elnakeeb Ayman

Mansoura university hospital

Phone: 0106752021

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place